These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31504056)

  • 21. Differential associations between depression and cognitive function in MCI and AD: a cross-sectional study.
    Lee CH; Kim DH; Moon YS
    Int Psychogeriatr; 2019 Aug; 31(8):1151-1158. PubMed ID: 30696505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
    Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
    Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spanish version of the Mattis Dementia Rating Scale-2 for early detection of Alzheimer's disease and mild cognitive impairment.
    Boycheva E; Contador I; Fernández-Calvo B; Ramos-Campos F; Puertas-Martín V; Villarejo-Galende A; Bermejo-Pareja F
    Int J Geriatr Psychiatry; 2018 Jun; 33(6):832-840. PubMed ID: 28332732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DemTect®--effective to asses MCI and dementia--validation study of the Polish language version.
    Wojtyńska R; Szcześniak D
    Aging Ment Health; 2016; 20(5):510-6. PubMed ID: 25811731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education.
    Radanovic M; Diniz BS; Mirandez RM; Novaretti TM; Flacks MK; Yassuda MS; Forlenza OV
    Int Psychogeriatr; 2009 Dec; 21(6):1081-7. PubMed ID: 19619390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation between amnestic-mild cognitive impairment and early-stage Alzheimer's disease using the Frontal Assessment Battery test.
    Yamao A; Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kasahara H; Nakayama K
    Psychogeriatrics; 2011 Dec; 11(4):235-41. PubMed ID: 22151243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early differentiation of dementia with Lewy bodies and Alzheimer's disease: Heart rate variability at mild cognitive impairment stage.
    Kim MS; Yoon JH; Hong JM
    Clin Neurophysiol; 2018 Aug; 129(8):1570-1578. PubMed ID: 29883835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.
    Lim YY; Ellis KA; Harrington K; Kamer A; Pietrzak RH; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Ames D; Maruff P;
    Neuropsychology; 2013 May; 27(3):322-332. PubMed ID: 23688214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing Approaches to Optimize Cut-off Scores for Short Cognitive Screening Instruments in Mild Cognitive Impairment and Dementia.
    O'Caoimh R; Gao Y; Svendovski A; Gallagher P; Eustace J; Molloy DW
    J Alzheimers Dis; 2017; 57(1):123-133. PubMed ID: 28222528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The IFS (INECO Frontal Screening) and level of education: Normative data.
    Sierra Sanjurjo N; Saraniti AB; Gleichgerrcht E; Roca M; Manes F; Torralva T
    Appl Neuropsychol Adult; 2019; 26(4):331-339. PubMed ID: 29432039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clock Drawing Test: A Simple Scoring System for the Accurate Screening of Cognitive Impairment in Patients with Mild Cognitive Impairment and Dementia.
    Rakusa M; Jensterle J; Mlakar J
    Dement Geriatr Cogn Disord; 2018; 45(5-6):326-334. PubMed ID: 30036864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity and specificity of the INECO frontal screening (IFS) in the detection of patients with traumatic brain injury presenting executive deficits.
    Pinasco C; Oviedo M; Goldfeder M; Bruno D; Lischinsky A; Torralva T; Roca M
    Appl Neuropsychol Adult; 2023; 30(3):289-296. PubMed ID: 34156897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. INECO frontal screening: an instrument to assess executive dysfunction in schizophrenia.
    Silva T; Monteiro L; Lopes E
    Span J Psychol; 2014; 17():E19. PubMed ID: 25012692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.